{"id":23112,"date":"2018-01-26T09:00:43","date_gmt":"2018-01-26T17:00:43","guid":{"rendered":"http:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/01\/26\/gw-pharma-aiming-for-fda-approval-for-cbd-drug-this-year-again\/"},"modified":"2018-01-27T13:00:57","modified_gmt":"2018-01-27T21:00:57","slug":"gw-pharma-aiming-for-fda-approval-for-cbd-drug-this-year-again","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/01\/26\/gw-pharma-aiming-for-fda-approval-for-cbd-drug-this-year-again\/","title":{"rendered":"GW Pharma aiming for FDA approval for CBD drug this year, again"},"content":{"rendered":"<\/p>\n<p>British cannabis company GW Pharmaceuticals is hoping the U.S. Food and Drug Administration will sign off on its CBD-based epilepsy treatment, Epidiolex, as soon as this year. According to The Washington Post, GW is hoping to get the green light from the FDA to classify Epidiolex as a prescription drug, despite the fact it\u2019s derived [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/gw-pharma-aiming-fda-approval-cbd-drug-year\/\">GW Pharma aiming for FDA approval for CBD drug this year, again<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/gw-pharma-aiming-fda-approval-cbd-drug-year\/\" target=\"_blank\">GW Pharma aiming for FDA approval for CBD drug this year, again<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>British cannabis company GW Pharmaceuticals is hoping the U.S. Food and Drug Administration will sign off on its CBD-based epilepsy treatment, Epidiolex, as soon as this year. According to The Washington Post, GW is hoping to get the green light from the FDA to classify Epidiolex as a prescription drug,<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/01\/26\/gw-pharma-aiming-for-fda-approval-for-cbd-drug-this-year-again\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,136,3156,3157,2786,3158,32,139],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/23112"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=23112"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/23112\/revisions"}],"predecessor-version":[{"id":23113,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/23112\/revisions\/23113"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=23112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=23112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=23112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}